Boehringer posts BI 1291583 bioavailability results; registers three new trialsNov 9Weekly roundup, 4 itemsBoehringer Ingelheimzongertinib
FDA grants accelerated approval to zongertinib for expanded lung cancer indicationNov 6Regulatory decisionzongertinib
Boehringer posts zongertinib hepatic PK results; adds NYU-led empagliflozin dialysis trial updateNov 6Weekly roundup, 4 itemsBoehringer IngelheimempagliflozinUpdated
Boehringer posts Phase III AIRWARD COPD trial for verducatib; also lists Phase I BI 3821001 studyOct 30Weekly roundup, 5 itemsBoehringer IngelheimzongertinibUpdated
MD Anderson registers Phase 1a/1b trial combining Jazz's zanidatamab with Boehringer's zongertinib iOct 28Trial updateBoehringer IngelheimJazz Pharmaceuticals
Sign inSign in